Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Scott

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Bioconjugate Chemistry|January 1, 1994
Preparation and characterization of interleukin-2-gelonin conjugates made using different cross-linking reagentsG D McIntyre, C F Scott, J Ritz, et al.
Journal of the National Cancer Institute|May 16, 1990
Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4R J Sharpe, H R Byers, C F Scott, et al.
Transactions of the Association of American Physicians|January 1, 1984
Regulation of the coagulant activity and surface binding of high molecular weight kininogenR W Colman, L D Silver, A D Purdon, et al.
Cancer Treatment and Research|January 1, 1988
Immunotoxins containing single-chain ribosome-inactivating proteinsJ M Lambert, W A Blättler, G D McIntyre, et al.
Transactions of the Association of American Physicians|January 1, 1985
Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIfC F Scott, R W Carrell, C B Glaser, et al.
The Journal of Biological Chemistry|November 5, 1993
Genetic basis of total kininogen deficiency in Williams' traitP P Cheung, S P Kunapuli, C F Scott, et al.
Journal of the National Cancer Institute|November 1, 1987
An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumorsC F Scott, V S Goldmacher, J M Lambert, et al.
Thrombosis and Haemostasis|December 14, 1999
Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosisM Cugno, C F Scott, F Salerno, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1988
Activation of the contact system of plasma proteolysis in the adult respiratory distress syndromeA C Carvalho, S DeMarinis, C F Scott, et al.
The Journal of Clinical Investigation|May 1, 1988
Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cellsC F Scott, W A Blättler, J M Lambert, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Bioconjugate Chemistry|January 1, 1994
Preparation and characterization of interleukin-2-gelonin conjugates made using different cross-linking reagentsG D McIntyre, C F Scott, J Ritz, et al.
Journal of the National Cancer Institute|May 16, 1990
Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4R J Sharpe, H R Byers, C F Scott, et al.
Transactions of the Association of American Physicians|January 1, 1984
Regulation of the coagulant activity and surface binding of high molecular weight kininogenR W Colman, L D Silver, A D Purdon, et al.
Cancer Treatment and Research|January 1, 1988
Immunotoxins containing single-chain ribosome-inactivating proteinsJ M Lambert, W A Blättler, G D McIntyre, et al.
Transactions of the Association of American Physicians|January 1, 1985
Alpha 1-antitrypsin-Pittsburgh: a potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIfC F Scott, R W Carrell, C B Glaser, et al.
The Journal of Biological Chemistry|November 5, 1993
Genetic basis of total kininogen deficiency in Williams' traitP P Cheung, S P Kunapuli, C F Scott, et al.
Journal of the National Cancer Institute|November 1, 1987
An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumorsC F Scott, V S Goldmacher, J M Lambert, et al.
Thrombosis and Haemostasis|December 14, 1999
Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosisM Cugno, C F Scott, F Salerno, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1988
Activation of the contact system of plasma proteolysis in the adult respiratory distress syndromeA C Carvalho, S DeMarinis, C F Scott, et al.
The Journal of Clinical Investigation|May 1, 1988
Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cellsC F Scott, W A Blättler, J M Lambert, et al.
Pageof 8